Clinical Trial Update: Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial update on treprostinil for patients with pulmonary arterial hypertension associated with interstitial lung disease, including results posted in 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis
• Interstitial Lung Disease
• Pulmonary Arterial Hypertension

Drugs mentioned

• Treprostinil (treprostinil)

Snippet

Sponsor: Rajan Saggar | Conditions: Pulmonary Arterial Hypertension, Interstitial Lung Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-09-09